A multidisciplinary team lead by American Fellowship-trained surgical oncologist Dr. Yasir Akmal, Staff Physician in the Digestive Disease Institute at Cleveland Clinic Abu Dhabi, oversaw this ground-breaking treatment.
Appendiceal tumors are present in about 1.4% of people who have an appendectomy and make up less than 1% of all cancers globally.
The patient's appendix was removed since she first displayed symptoms similar to appendicitis.
Her surgeon, however, found gelatinous deposits—a jelly-like substance—in the abdominal cavity during the treatment.
A later pathology report verified the existence of a rare low-grade mucinous neoplasm, a tumor that could spread across the abdomen and cause pseudomyxoma peritonei, also referred to as "jelly belly," if left untreated.
"We are pushing the boundaries of robotic surgery and are proud to have used such advanced technology for a complex procedure like Paola's," stated Dr. Georges-Pascal Haber, Chief Executive Officer of Cleveland Clinic Abu Dhabi. Leading the way in surgical innovation, Cleveland Clinic Abu Dhabi is always improving minimally invasive procedures to boost quality of life and improve results.
Her surgeon, however, found gelatinous deposits—a jelly-like substance—in the abdominal cavity during the treatment.
A later pathology report verified the existence of a rare low-grade mucinous neoplasm, a tumor that could spread across the abdomen and cause pseudomyxoma peritonei, also referred to as "jelly belly," if left untreated.
"We are pushing the boundaries of robotic surgery and are proud to have used such advanced technology for a complex procedure like Paola's," stated Dr. Georges-Pascal Haber, Chief Executive Officer of Cleveland Clinic Abu Dhabi. Leading the way in surgical innovation, Cleveland Clinic Abu Dhabi is always improving minimally invasive procedures to boost quality of life and improve results.
Post a Comment